caramiphen hydrochloride
Small moleculeexperimental
Caramiphen is a muscarinic M1 acetylcholine receptor antagonist, which was used for the treatment of Parkinson Disease and cough, but then there using were discontinued. Caramiphen is also used in local anesthesia, and effect could be achieved through the suppression of voltage-gated Na⁺ currents. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Indications
Approved for
Chemistry & pharmacology
Loading structure…
SMILES
CCN(CC)CCOC(=O)C1(c2ccccc2)CCCC1- Mol. weight
- 289.42 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL61946 ↗
- NCATS97J7NP0XJY ↗
- ChEMBLCHEMBL1598472 ↗
Also known as
- caraminphen
- caramiphen
- caramiphen
- caramiphen
- caramiphen
- caramiphen edisilate
- caramiphen edisilate
- caramiphen edisilate
- caramiphen hcl
- caramiphen hydrochloride
- panparnit